WGS
GeneDx Holdings Corp.
Price Chart
Latest Quote
$99.01
Current Price| Previous Close | $96.26 |
| Open | $96.86 |
| Day High | $101.50 |
| Day Low | $96.50 |
| Volume | 574,990 |
Stock Information
| Shares Outstanding | 28.90M |
| Total Debt | $113.16M |
| Cash Equivalents | $155.08M |
| Revenue | $402.19M |
| Net Income | $2.08M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $2.86B |
| P/E Ratio | 900.09 |
| EPS (TTM) | $0.11 |
| Exchange | NMS |
đ Custom Metrics & Score
Score: 11/42| Debt to Equity | 0.47 |
| Debt to Earnings | 0.60 |
| Current Ratio | 3.61 |
| Quick Ratio | 3.26 |
| Avg Revenue Growth | 10.99% |
| Profit Margin | -17.12% |
| Return on Equity | -21.32% |
| Avg FCF Growth | -20.98% |
| FCF Yield | -1.19% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $99.01 | 575,000 |
| 2026-01-30 | $96.26 | 637,400 |
| 2026-01-29 | $98.16 | 554,900 |
| 2026-01-28 | $95.29 | 737,900 |
| 2026-01-27 | $96.01 | 900,900 |
| 2026-01-26 | $104.88 | 393,300 |
| 2026-01-23 | $101.35 | 592,700 |
| 2026-01-22 | $101.88 | 873,500 |
| 2026-01-21 | $100.04 | 651,700 |
| 2026-01-20 | $99.68 | 1,130,100 |
| 2026-01-16 | $108.08 | 706,500 |
| 2026-01-15 | $109.28 | 1,292,900 |
| 2026-01-14 | $104.56 | 720,400 |
| 2026-01-13 | $109.84 | 903,800 |
| 2026-01-12 | $119.24 | 2,147,700 |
| 2026-01-09 | $135.38 | 464,400 |
| 2026-01-08 | $137.47 | 295,900 |
| 2026-01-07 | $136.55 | 336,100 |
| 2026-01-06 | $135.80 | 233,500 |
| 2026-01-05 | $131.50 | 474,700 |
About GeneDx Holdings Corp.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut.
đ° Latest News
GeneDx Partners With Komodo Health to Advance Rare Disease Research
Zacks âĸ 2026-01-12T14:56:00Z
Is GeneDx Holdings (WGS) Pricing Look Attractive After Mixed Long Term Share Performance
Simply Wall St. âĸ 2026-01-07T20:09:13Z
A Look At GeneDx Holdings (WGS) Valuation After New CMO Appointment And Record Rare Disease Genomics Year
Simply Wall St. âĸ 2026-01-07T00:18:40Z
What Do Analysts Think About GeneDx Holdings Corp. (WGS)?
Insider Monkey âĸ 2025-12-31T04:47:03Z
3 Stocks That May Be Priced Below Their Estimated Worth In December 2025
Simply Wall St. âĸ 2025-12-23T17:38:14Z
3 Stocks Estimated To Be Trading Below Fair Value By Up To 46%
Simply Wall St. âĸ 2025-12-23T11:37:55Z
GeneDx Holdings Corp. (NASDAQ:WGS) Shares Could Be 40% Below Their Intrinsic Value Estimate
Simply Wall St. âĸ 2025-12-14T12:15:13Z
Cathie Wood Dumps Tesla Again, Pours Millions Into This Tech Gaint
GuruFocus.com âĸ 2025-12-09T12:58:14Z
TSLA: Cathie Wood Dumps Millions in Tesla and Meta Shares
GuruFocus.com âĸ 2025-12-05T15:11:49Z
3 Stocks Estimated To Be Undervalued By Up To 46.2%
Simply Wall St. âĸ 2025-11-19T17:38:14Z
Income Statement (Annual)
Revenue
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Reconciled Cost Of Revenue | $111,053,000 | $112,560,000 | $261,444,000 | $228,797,000 |
| Cost Of Revenue | $111,053,000 | $112,560,000 | $261,444,000 | $228,797,000 |
| Total Revenue | $305,450,000 | $202,566,000 | $234,694,000 | $212,195,000 |
| Operating Revenue | $302,157,000 | $195,654,000 | $227,334,000 | $205,100,000 |
Expenses
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Expenses | $328,663,000 | $372,760,000 | $692,201,000 | $658,344,000 |
| Other Income Expense | $-26,384,000 | $-7,613,000 | $-139,859,000 | $203,515,000 |
| Other Non Operating Income Expenses | $-13,014,000 | $1,619,000 | $57,000 | $5,114,000 |
| Net Non Operating Interest Income Expense | $-3,032,000 | $1,114,000 | $-666,000 | $-2,756,000 |
| Total Other Finance Cost | $3,032,000 | $-1,114,000 | $666,000 | - |
| Operating Expense | $217,610,000 | $260,200,000 | $430,757,000 | $429,547,000 |
| Other Operating Expenses | $3,407,000 | $7,223,000 | $6,312,000 | $5,659,000 |
| Selling And Marketing Expense | $67,371,000 | $60,956,000 | $122,075,000 | $112,738,000 |
| General And Administrative Expense | $101,110,000 | $133,755,000 | $216,167,000 | $205,988,000 |
| Interest Expense | - | - | $3,207,000 | $2,835,000 |
| Interest Expense Non Operating | - | - | $3,207,000 | $2,835,000 |
Income & Earnings
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $-52,286,000 | $-175,767,000 | $-548,980,000 | $-245,390,000 |
| Net Interest Income | $-3,032,000 | $1,114,000 | $-666,000 | $-2,756,000 |
| Normalized Income | $-38,996,220 | $-166,581,160 | $-420,537,112 | $-443,791,000 |
| Net Income From Continuing And Discontinued Operation | $-52,286,000 | $-175,767,000 | $-548,980,000 | $-245,390,000 |
| Total Operating Income As Reported | $-23,213,000 | $-180,596,000 | $-667,652,000 | $-446,149,000 |
| Net Income Common Stockholders | $-52,286,000 | $-175,767,000 | $-548,980,000 | $-245,390,000 |
| Net Income | $-52,286,000 | $-175,767,000 | $-548,980,000 | $-245,390,000 |
| Net Income Including Noncontrolling Interests | $-52,286,000 | $-175,767,000 | $-548,980,000 | $-245,390,000 |
| Net Income Continuous Operations | $-52,286,000 | $-175,767,000 | $-548,980,000 | $-245,390,000 |
| Pretax Income | $-52,629,000 | $-176,693,000 | $-598,032,000 | $-245,390,000 |
| Special Income Charges | $0 | $-10,402,000 | $-210,145,000 | $0 |
| Operating Income | $-23,213,000 | $-170,194,000 | $-457,507,000 | $-446,149,000 |
| Gross Profit | $194,397,000 | $90,006,000 | $-26,750,000 | $-16,602,000 |
| Interest Income | - | - | $2,541,000 | $79,000 |
| Interest Income Non Operating | - | - | $2,541,000 | $79,000 |
Per Share Metrics
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Diluted EPS | $-1.94 | $-7.23 | $-53.79 | $-74.91 |
| Basic EPS | $-1.94 | $-7.23 | $-53.79 | $-74.91 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $-80,220 | $-46,160 | $-11,473,112 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $12,110,000 | $-127,228,000 | $-258,282,000 | $-419,149,000 |
| Total Unusual Items | $-13,370,000 | $-9,232,000 | $-139,916,000 | $198,401,000 |
| Total Unusual Items Excluding Goodwill | $-13,370,000 | $-9,232,000 | $-139,916,000 | $198,401,000 |
| Reconciled Depreciation | $21,953,000 | $33,734,000 | $59,309,000 | $21,807,000 |
| EBITDA (Bullshit earnings) | $-1,260,000 | $-136,460,000 | $-398,198,000 | $-220,748,000 |
| EBIT | $-23,213,000 | $-170,194,000 | $-457,507,000 | $-242,555,000 |
| Diluted Average Shares | $26,891,213 | $24,311,989 | $10,236,959 | $3,275,073 |
| Basic Average Shares | $26,891,213 | $24,311,989 | $10,236,959 | $3,275,073 |
| Diluted NI Availto Com Stockholders | $-52,286,000 | $-175,767,000 | $-548,980,000 | $-245,390,000 |
| Tax Provision | $-343,000 | $-926,000 | $-49,052,000 | $0 |
| Write Off | $0 | $10,402,000 | $210,145,000 | $0 |
| Gain On Sale Of Security | $-13,370,000 | $1,170,000 | $70,229,000 | $198,401,000 |
| Research And Development | $45,722,000 | $58,266,000 | $86,203,000 | $105,162,000 |
| Selling General And Administration | $168,481,000 | $194,711,000 | $338,242,000 | $318,726,000 |
| Other Gand A | $101,110,000 | $133,755,000 | $216,167,000 | $205,988,000 |
Balance Sheet (Annual)
Assets
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Tangible Assets | $86,647,000 | $55,392,000 | $67,055,000 | $388,103,000 |
| Total Assets | $419,380,000 | $418,756,000 | $490,942,000 | $554,093,000 |
| Total Non Current Assets | $221,412,000 | $236,417,000 | $278,320,000 | $70,549,000 |
| Other Non Current Assets | $4,306,000 | $4,413,000 | $7,385,000 | $7,830,000 |
| Goodwill And Other Intangible Assets | $158,600,000 | $172,625,000 | $186,650,000 | $0 |
| Other Intangible Assets | $158,600,000 | $172,625,000 | $186,650,000 | - |
| Current Assets | $197,968,000 | $182,339,000 | $212,622,000 | $483,544,000 |
| Other Current Assets | $1,079,000 | $1,958,000 | $31,682,000 | $22,956,000 |
| Prepaid Assets | $7,425,000 | $8,640,000 | $11,822,000 | $19,154,000 |
| Inventory | $10,650,000 | $8,777,000 | $13,665,000 | $33,456,000 |
| Receivables | $37,629,000 | $32,816,000 | $43,342,000 | $26,563,000 |
| Accounts Receivable | $37,426,000 | $32,371,000 | $42,634,000 | $26,509,000 |
| Cash Cash Equivalents And Short Term Investments | $141,185,000 | $130,148,000 | $123,933,000 | $400,569,000 |
| Cash And Cash Equivalents | $85,212,000 | $99,681,000 | $123,933,000 | $400,569,000 |
| Restricted Cash | - | - | $13,470,000 | $0 |
Debt
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Debt | $116,168,000 | $119,273,000 | $77,134,000 | $11,000,000 |
| Long Term Debt And Capital Lease Obligation | $112,832,000 | $115,626,000 | $66,263,000 | $11,000,000 |
| Long Term Debt | $51,913,000 | $52,688,000 | $6,250,000 | $11,000,000 |
| Current Debt And Capital Lease Obligation | $3,336,000 | $3,647,000 | $10,871,000 | $3,419,000 |
| Current Debt | - | $497,000 | $4,750,000 | - |
| Other Current Borrowings | - | $497,000 | $4,750,000 | - |
Liabilities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $174,133,000 | $190,739,000 | $237,237,000 | $165,990,000 |
| Total Non Current Liabilities Net Minority Interest | $119,316,000 | $131,921,000 | $92,940,000 | $64,706,000 |
| Derivative Product Liabilities | $3,519,000 | $2,735,000 | $418,000 | $21,555,000 |
| Non Current Deferred Liabilities | $965,000 | $1,560,000 | $2,659,000 | $0 |
| Non Current Deferred Taxes Liabilities | $965,000 | $1,560,000 | $2,659,000 | $0 |
| Current Liabilities | $54,817,000 | $58,818,000 | $144,297,000 | $101,284,000 |
| Other Current Liabilities | $2,843,000 | $2,018,000 | $24,666,000 | $8,930,000 |
| Payables And Accrued Expenses | $21,065,000 | $23,796,000 | $78,560,000 | $78,320,000 |
| Payables | $9,561,000 | $11,617,000 | $49,610,000 | $47,316,000 |
| Accounts Payable | $7,954,000 | $10,238,000 | $46,017,000 | $44,693,000 |
| Other Non Current Liabilities | - | - | $1,600,000 | $32,151,000 |
| Current Deferred Liabilities | - | - | $40,000 | $473,000 |
Equity
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Common Stock Equity | $245,247,000 | $228,017,000 | $253,705,000 | $388,103,000 |
| Total Equity Gross Minority Interest | $245,247,000 | $228,017,000 | $253,705,000 | $388,103,000 |
| Stockholders Equity | $245,247,000 | $228,017,000 | $253,705,000 | $388,103,000 |
| Gains Losses Not Affecting Retained Earnings | $830,000 | $425,000 | $0 | - |
| Other Equity Adjustments | $830,000 | $425,000 | - | - |
| Retained Earnings | $-1,352,474,000 | $-1,300,188,000 | $-1,124,421,000 | $-575,441,000 |
| Preferred Securities Outside Stock Equity | - | - | - | $0 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Ordinary Shares Number | $28,016,545 | $25,978,863 | $11,773,064 | $7,352,957 |
| Share Issued | $28,016,545 | $25,978,863 | $11,773,064 | $7,352,957 |
| Tangible Book Value | $86,647,000 | $55,392,000 | $67,055,000 | $388,103,000 |
| Invested Capital | $297,160,000 | $280,705,000 | $264,705,000 | $399,103,000 |
| Working Capital | $143,151,000 | $123,521,000 | $68,325,000 | $382,260,000 |
| Capital Lease Obligations | $64,255,000 | $66,585,000 | $66,134,000 | $0 |
| Total Capitalization | $297,160,000 | $280,705,000 | $259,955,000 | $399,103,000 |
| Additional Paid In Capital | $1,596,889,000 | $1,527,778,000 | $1,378,125,000 | $963,520,000 |
| Capital Stock | $2,000 | $2,000 | $1,000 | $24,000 |
| Common Stock | $2,000 | $2,000 | $1,000 | $24,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $60,919,000 | $62,938,000 | $60,013,000 | $0 |
| Long Term Provisions | $2,000,000 | $12,000,000 | $22,000,000 | - |
| Current Capital Lease Obligation | $3,336,000 | $3,647,000 | $6,121,000 | $0 |
| Pensionand Other Post Retirement Benefit Plans Current | $16,987,000 | $14,318,000 | $13,199,000 | $13,561,000 |
| Current Provisions | $10,586,000 | $15,039,000 | $17,001,000 | - |
| Current Accrued Expenses | $11,504,000 | $12,179,000 | $28,950,000 | $31,004,000 |
| Dueto Related Parties Current | $1,607,000 | $1,379,000 | $3,593,000 | $2,623,000 |
| Net PPE | $58,506,000 | $59,379,000 | $84,285,000 | $62,719,000 |
| Accumulated Depreciation | $-52,478,000 | $-46,452,000 | $-101,460,000 | $-51,906,000 |
| Gross PPE | $110,984,000 | $105,831,000 | $185,745,000 | $114,625,000 |
| Leases | $14,655,000 | $14,614,000 | $35,561,000 | $21,905,000 |
| Construction In Progress | $4,960,000 | $3,106,000 | $3,386,000 | $940,000 |
| Other Properties | $47,173,000 | $45,042,000 | $95,397,000 | $49,936,000 |
| Machinery Furniture Equipment | $39,667,000 | $38,540,000 | $45,125,000 | $35,568,000 |
| Buildings And Improvements | $4,529,000 | $4,529,000 | $6,276,000 | $6,276,000 |
| Properties | $0 | $0 | $0 | $0 |
| Duefrom Related Parties Current | $203,000 | $445,000 | $708,000 | $54,000 |
| Other Short Term Investments | $55,973,000 | $30,467,000 | $0 | - |
| Current Deferred Revenue | - | - | $40,000 | $473,000 |
| Employee Benefits | - | - | - | $0 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | $-33,987,000 | $-185,858,000 | $-333,477,000 | $-211,220,000 |
Operating Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Operating Cash Flow | $-28,496,000 | $-180,147,000 | $-319,155,000 | $-190,434,000 |
| Cash Flow From Continuing Operating Activities | $-28,496,000 | $-180,147,000 | $-319,155,000 | $-190,434,000 |
| Operating Gains Losses | $13,370,000 | $-5,597,000 | $-70,229,000 | $-198,100,000 |
Investing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Capital Expenditure | $-5,491,000 | $-5,711,000 | $-14,322,000 | $-20,786,000 |
| Investing Cash Flow | $-30,132,000 | $-43,726,000 | $-141,326,000 | $-20,786,000 |
| Cash Flow From Continuing Investing Activities | $-30,132,000 | $-43,726,000 | $-141,326,000 | $-20,786,000 |
| Net Other Investing Changes | - | $-8,110,000 | - | - |
Financing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Issuance Of Capital Stock | $46,496,000 | $143,002,000 | $197,659,000 | $442,684,000 |
| Financing Cash Flow | $44,162,000 | $186,238,000 | $197,315,000 | $493,729,000 |
| Cash Flow From Continuing Financing Activities | $44,162,000 | $186,238,000 | $197,315,000 | $493,729,000 |
| Net Common Stock Issuance | $46,496,000 | $143,002,000 | $197,659,000 | $442,684,000 |
| Common Stock Issuance | $46,496,000 | $143,002,000 | $197,659,000 | $442,684,000 |
| Net Other Financing Charges | - | - | $197,659,000 | $63,243,000 |
| Net Preferred Stock Issuance | - | - | $0 | $0 |
| Preferred Stock Issuance | - | - | $0 | $0 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Repayment Of Debt | $-3,225,000 | $-5,598,000 | $-3,292,000 | $-13,469,000 |
| Issuance Of Debt | $0 | $48,549,000 | $0 | $0 |
| Interest Paid Supplemental Data | $6,677,000 | $3,041,000 | $1,932,000 | $2,751,000 |
| Income Tax Paid Supplemental Data | $1,167,000 | $1,465,000 | $1,241,000 | $349,000 |
| End Cash Position | $86,202,000 | $100,668,000 | $138,303,000 | $401,469,000 |
| Beginning Cash Position | $100,668,000 | $138,303,000 | $401,469,000 | $118,960,000 |
| Changes In Cash | $-14,466,000 | $-37,635,000 | $-263,166,000 | $282,509,000 |
| Proceeds From Stock Option Exercised | $891,000 | $285,000 | $2,948,000 | $1,271,000 |
| Net Issuance Payments Of Debt | $-3,225,000 | $42,951,000 | $-3,292,000 | $-13,469,000 |
| Net Long Term Debt Issuance | $-3,225,000 | $42,951,000 | $-3,292,000 | $-13,469,000 |
| Long Term Debt Payments | $-3,225,000 | $-5,598,000 | $-3,292,000 | $-13,469,000 |
| Long Term Debt Issuance | $0 | $48,549,000 | $0 | $0 |
| Net Investment Purchase And Sale | $-24,641,000 | $-29,905,000 | $0 | - |
| Sale Of Investment | $41,661,000 | $17,765,000 | $0 | - |
| Purchase Of Investment | $-66,302,000 | $-47,670,000 | $0 | - |
| Net Intangibles Purchase And Sale | $0 | $-461,000 | $-7,166,000 | $-11,386,000 |
| Purchase Of Intangibles | $0 | $-461,000 | $-7,166,000 | $-11,386,000 |
| Net PPE Purchase And Sale | $-5,491,000 | $-5,250,000 | $-7,156,000 | $-9,400,000 |
| Purchase Of PPE | $-5,491,000 | $-5,250,000 | $-7,156,000 | $-9,400,000 |
| Change In Working Capital | $-24,745,000 | $-38,241,000 | $33,881,000 | $8,078,000 |
| Change In Other Working Capital | $3,722,000 | $-2,526,000 | $-8,455,000 | $123,000 |
| Change In Payables And Accrued Expense | $-20,461,000 | $-46,953,000 | $34,459,000 | $25,916,000 |
| Change In Inventory | $-2,585,000 | $975,000 | $2,350,000 | $-10,624,000 |
| Change In Receivables | $-5,421,000 | $10,263,000 | $5,527,000 | $5,535,000 |
| Changes In Account Receivables | $-5,421,000 | $10,263,000 | $5,527,000 | $5,535,000 |
| Other Non Cash Items | $4,237,000 | $-7,339,000 | $2,743,000 | $1,621,000 |
| Stock Based Compensation | $9,138,000 | $-326,000 | $41,975,000 | $219,421,000 |
| Provisionand Write Offof Assets | $180,000 | $3,913,000 | $1,125,000 | $2,129,000 |
| Asset Impairment Charge | $0 | $10,402,000 | $210,145,000 | $0 |
| Deferred Tax | $-343,000 | $-926,000 | $-49,124,000 | $0 |
| Deferred Income Tax | $-343,000 | $-926,000 | $-49,124,000 | $0 |
| Depreciation Amortization Depletion | $21,953,000 | $33,734,000 | $59,309,000 | $21,807,000 |
| Depreciation And Amortization | $21,953,000 | $33,734,000 | $59,309,000 | $21,807,000 |
| Gain Loss On Investment Securities | $13,370,000 | $-1,170,000 | $-70,229,000 | $-198,401,000 |
| Net Income From Continuing Operations | $-52,286,000 | $-175,767,000 | $-548,980,000 | $-245,390,000 |
| Net Business Purchase And Sale | - | $-12,144,000 | $-127,004,000 | $0 |
| Purchase Of Business | - | $-12,144,000 | $-127,004,000 | $0 |
| Change In Other Current Liabilities | - | - | $-19,467,000 | $3,239,000 |
| Change In Other Current Assets | - | - | $-2,000 | $-1,861,000 |
| Change In Prepaid Assets | - | - | $11,130,000 | $-14,250,000 |